Nisa Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Sell |
1,121
-1,002
| -47% | -$9.24K | ﹤0.01% | 2246 |
|
|
2025
Q1 | $18.2K | Sell |
2,123
-138
| -6% | -$1.18K | ﹤0.01% | 1921 |
|
|
2024
Q4 | $24.3K | Buy |
2,261
+434
| +24% | +$4.66K | ﹤0.01% | 1880 |
|
|
2024
Q3 | $10.4K | Hold |
1,827
| – | – | ﹤0.01% | 2090 |
|
|
2024
Q2 | $7.71K | Buy |
1,827
+192
| +12% | +$810 | ﹤0.01% | 2210 |
|
|
2024
Q1 | $8.32K | Buy |
1,635
+85
| +5% | +$433 | ﹤0.01% | 2067 |
|
|
2023
Q4 | $14.4K | Sell |
1,550
-24
| -2% | -$223 | ﹤0.01% | 1955 |
|
|
2023
Q3 | $10.3K | Sell |
1,574
-16
| -1% | -$105 | ﹤0.01% | 2171 |
|
|
2023
Q2 | $12.9K | Sell |
1,590
-710
| -31% | -$5.77K | ﹤0.01% | 2212 |
|
|
2023
Q1 | $20K | Buy |
2,300
+1,600
| +229% | +$13.9K | ﹤0.01% | 2005 |
|
|
2022
Q4 | $6K | Sell |
700
-60
| -8% | -$514 | ﹤0.01% | 2272 |
|
|
2022
Q3 | $9K | Buy |
760
+60
| +9% | +$711 | ﹤0.01% | 2201 |
|
|
2022
Q2 | $7K | Hold |
700
| – | – | ﹤0.01% | 2231 |
|
|
2022
Q1 | $9K | Buy |
+700
| New | +$9K | ﹤0.01% | 2217 |
|
|
2021
Q4 | – | Sell |
-990
| Closed | -$18 | – | 2214 |
|
|
2021
Q3 | $18 | Hold |
990
| – | – | ﹤0.01% | 2111 |
|
|
2021
Q2 | $23 | Buy |
+990
| New | +$23 | ﹤0.01% | 2107 |
|